盐水全血阻抗聚集法检测非肝素依赖性血小板活化抗PF4抗体
本研究评估在肝素诱导的血小板减少症(HIT)功能检测中,将盐水条件纳入全血阻抗聚集法(WBIA),以识别具有非肝素依赖性血小板活化特性的高致病性抗血小板因子4(PF4)抗体亚组。2023至2025年分析150例可评估患者,盐水阳性组较经典阳性组HIT相关血栓形成、迟发性HIT、难治性HIT及自发性HIT发生率均显著更高,且全部归为自身免疫性HIT。
要点
- 盐水阳性WBIA识别非肝素依赖性自身免疫性HIT表型,血栓风险更高。
- 盐水阳性组HIT相关血栓形成发生率为89%,经典阳性组为54%。
- 高剂量静脉免疫球蛋白可实时中和盐水阳性反应。
核心结论
- WBIA盐水阳性可识别非肝素依赖性自身免疫性HIT表型,其致病性和血栓风险更高。
研究设计与样本
- 2023至2025年分析150例可评估患者,其中WBIA阴性65例、WBIA阳性85例。
- WBIA阳性分为经典阳性组(仅低剂量肝素阳性,n=46)和盐水阳性组(低剂量肝素和盐水均阳性,n=35)。
- 以血液科医生临床诊断HIT为参考,PF4/IgG采用化学发光免疫分析法检测。
- WBIA分别采用低剂量肝素、高剂量肝素和盐水条件进行,并分析可获得的血清素释放试验(SRA)结果。
主要发现
- 盐水阳性组较经典阳性组HIT相关血栓形成发生率显著更高(89% vs 54%,P = .005)。
- 盐水阳性组较经典阳性组迟发性HIT发生率显著更高(23% vs 0%,P = .001)。
- 盐水阳性组较经典阳性组难治性HIT发生率显著更高(40% vs 7%,P < .001)。
- 盐水阳性组较经典阳性组自发性HIT发生率显著更高(14% vs 0%,P = .013)。
- 盐水阳性组较经典阳性组静脉血栓栓塞(肺栓塞和深静脉血栓)更多(P < .05)。
关键数值与推荐
- 盐水阳性组HIT相关血栓形成89% vs 经典阳性组54%(P = .005)。
- 盐水阳性组迟发性HIT 23% vs 经典阳性组0%(P = .001)。
- 盐水阳性组难治性HIT 40% vs 经典阳性组7%(P < .001)。
- 盐水阳性组自发性HIT 14% vs 经典阳性组0%(P = .013)。
- 自发性HIT亚组SRA假阴性率为57.1%。
临床怎么用
- 盐水WBIA方案可快速识别高致病性抗PF4抗体,弥补标准双条件SRA可能失败的诊断缺口。
- 盐水阳性结果提示非肝素依赖性自身免疫性HIT表型,可指导临床管理。
- 高剂量静脉免疫球蛋白可实时中和盐水阳性反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study evaluates the practice of incorporating a saline testing condition into the heparin-induced thrombocytopenia (HIT) functional assay using whole-blood impedance aggregometry (WBIA) to identify a subgroup of highly pathogenic anti-platelet factor 4 (PF4) antibodies with heparin-independent platelet-activating properties. METHODS: From 2023 to 2025, we analyzed 150 evaluable patients (65 WBIA Negative, 85 WBIA Positive). Positive cases were subdivided into Classic-Positive (low-dose heparin positive only; n = 46) and Saline-Positive (positive under both low-dose heparin and saline; n = 35). The diagnosis of clinical HIT by hematologists was used as reference. PF4/IgG was measured by chemiluminescent immunoassay; WBIA was performed with low-dose heparin, high-dose heparin, and saline; and available serotonin release assay (SRA) results were analyzed. RESULTS: Saline-Positive patients exhibited significantly higher incidences of HIT-associated thrombosis (89% vs 54%, P = .005), delayed-onset HIT (23% vs 0%, P = .001), refractory HIT (40% vs 7%, P < .001), spontaneous HIT (14% vs 0%, P = .013), and more venous thromboembolism (pulmonary embolism and deep vein thrombosis, P < .05) compared with Classic-Positive patients. All 35 Saline-Positive cases were classified as autoimmune HIT (aHIT). The spontaneous HIT subset (n = 5) displayed a distinct pattern of low-titer anti-PF4 antibodies discordant with strong saline-WBIA reactivity and a high SRA false-negative rate (57.1%). High-dose intravenous immunoglobulin neutralized saline positivity in real time. CONCLUSIONS: Saline-positivity in WBIA identifies a heparin-independent aHIT phenotype with higher pathogenicity and thrombotic risk. This rapid saline protocol addresses diagnostic gaps where standard 2-condition SRA protocols may fail, offering a practical tool to identify high-pathogenic anti-PF4 antibodies and guide clinical management.
引用
- Jin J, Yang LM, Zhang J, et al. Saline whole-blood impedance aggregometry for detection of heparin-independent platelet-activating anti-platelet factor 4 antibodies. Am J Clin Pathol. 2026. PMID: 42722359. doi:10.1093/ajcp/aqag100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。